PSYBF (PsyBio Therapeutics) Total Liabilities: $1.97 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PsyBio Therapeutics Total Liabilities?

PsyBio Therapeutics PSYBF -90.00% Total Liabilities is $1.97 Mil as of Jun. 2023.

PsyBio Therapeutics's Total Liabilities for the quarter that ended in Jun. 2023 was $1.97 Mil.

PsyBio Therapeutics's quarterly Total Liabilities declined from Dec. 2022 ($1.98 Mil) to Mar. 2023 ($1.96 Mil) but then increased from Mar. 2023 ($1.96 Mil) to Jun. 2023 ($1.97 Mil).

PsyBio Therapeutics's annual Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2021 ($1.29 Mil) and increased from Dec. 2021 ($1.29 Mil) to Dec. 2022 ($1.98 Mil).

PsyBio Therapeutics Total Liabilities Historical Data

* Premium members only.

The historical data trend for PsyBio Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PsyBio Therapeutics Total Liabilities Chart

PsyBio Therapeutics Annual Data
Trend Dec21 Dec22
Total Liabilities
1.29 1.98

PsyBio Therapeutics Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.26 1.32 1.98 1.96 1.97

PsyBio Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PsyBio Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.931+(0+0.05
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.98

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=0.39--1.591
=1.98

PsyBio Therapeutics's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.971+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.97

Total Liabilities=Total Assets (Q: Jun. 2023 )-Total Equity (Q: Jun. 2023 )
=0.283--1.688
=1.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $1.97 Mil mean?
PsyBio Therapeutics (PSYBF) has a Total Liabilities of $1.97 Mil as of Jun. 2023. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PsyBio Therapeutics and its competitors.
Is PsyBio Therapeutics' Total Liabilities too high?
PsyBio Therapeutics' current Total Liabilities is $1.97 Mil.
How does PsyBio Therapeutics' Total Liabilities compare to VRTX and REGN?
PsyBio Therapeutics' Total Liabilities of $1.97 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PsyBio Therapeutics and its competitors. PsyBio Therapeutics's current Total Liabilities is $1.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PsyBio Therapeutics stock overvalued right now?
PsyBio Therapeutics (PSYBF) has a current Total Liabilities of $1.97 Mil. The current Total Liabilities is $1.97 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For PsyBio Therapeutics (PSYBF), the current Total Liabilities is $1.97 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PsyBio Therapeutics Business Description

Address 1624 Washington Street, Denver, CO, USA, 80203
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.